IL-1β Reporter HEK 293 Cells
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
HEK-Blue™ IL-1β Cells HEK 293 reporter cells for human and murine IL-1β cytokines |
Show product |
3-7 x 10e6 cells |
hkb-il1bv2
|
|
Notification: : This cell line has been replaced with another clone which is KO for TLR3, TLR5, and TNFR1. Thus, it has a new cat. code: hkb-il1bv2.
This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.
IL-1Beta Reporter Cells
HEK-Blue™ IL-1β Cells signaling pathway
HEK-Blue™ IL-1β cells were engineered from the human embryonic kidney HEK 293 cell line to detect bioactive interleukin-1β (IL-1β) by monitoring the activation of the NF-κB and AP-1 pathways. These cells are useful to monitor IL-1β secretion in inflammasome activation studies. They can also be used for screening anti-IL-1β antibodies.
IL-1β is a soluble pro-inflammatory cytokine that plays a critical role in the host response to infection and injury [1].
Cell line description:
HEK-Blue™ IL-1β cells derive from the HEK-Blue™ Null-1v cell line which expresses an NF-κB/AP-1 inducible secreted embryonic alkaline phosphatase (SEAP) reporter. Binding of IL-1 to its receptor on the surface of HEK-Blue™ IL-1β cells triggers a signaling cascade leading to the activation NF-κB/AP-1 and the subsequent production of SEAP. Levels of SEAP can be easily monitored using QUANTI-Blue™ Solution.
HEK-Blue™ IL-1β cells respond to both human IL-1α and IL-1β, as these cytokines bind to the same receptor, IL-1R1. They also respond to a lesser extent to murine IL-1α and IL-1β. The specificity of the HEK-Blue™ IL-1β cells for the detection of IL-1α or IL-1β can be confirmed using a neutralizing antibody against human IL-1α or IL-1β, such as anti-hIL-1α-IgG and anti-hIL-1β-IgG.
The parental HEK-Blue™ Null-1v cell line expresses endogenous levels of TLR3, TLR5, and TFNR1, which all signal through NF-κB and AP-1 pathways. The genes encoding these three receptors have been knocked out in HEK-Blue™ IL-1β cells, to avoid interferences between activation of the NF-κB/AP-1 pathways through IL-1β or ligands of TLR3, TLR5, or TNFAR. Thus, this reporter cell line can be used to monitor IL-1β production upon TLR3, TLR5, or TFNAR activation with Poly(I:C), Flagellin, or TNFα, respectively.
Features of HEK-Blue™ IL-1β cells:
- Fully functional IL-1β signaling pathway
- Do not respond to human or murine TNF-α
- Do not respond to TLR3 and TLR5 agonists
- Readily assessable SEAP reporter activity
- Functionally tested and guaranteed mycoplasma-free
Applications of HEK-Blue™ IL-1β cells:
- Detection of human IL-1β (0.1 - 100 ng/ml), and to a lesser extent murine IL-1β (10 -1000 ng/ml)
- Detection of IL-1β in inflammasome studies
- Screening of anti-IL-1β antibodies
Download our Practical guide on Inflammasomes
Reference:
1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8–27.
Back to the topSpecifications
Antibiotic resistance: Zeocin®
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-Glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™
Guaranteed mycoplasma-free
Detects human and murine IL-1β (α)
- Detection range for human IL-1β: 100 pg - 100 ng/ml
- Detection range for murine IL-1β: 10 ng - 1 µg/ml
This product is covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 1 vial containing 3-5 x 106 cells
- 1 ml of Zeocin® (100 mg/ml)
- 1 ml of Normocin™ (50 mg/ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada and some areas in Asia)
Back to the topDetails
IL-1β is a soluble pro-inflammatory cytokine that plays a critical role in the host response to infection and injury [1]. It is synthesized as a pro-IL-1β zymogen by activated macrophages and must be cleaved by caspase-1 to generate its mature form [2]. IL-1β binding to the IL-1R1 receptor triggers the formation of the IL-1R1/IL-1R3/MyD88 complex and induces signaling leading to the activation of the transcription factors NK-κB and AP-1 [3]. Due to its role in mediating acute and chronic inflammation, IL-1β has emerged as a therapeutic target for auto-inflammatory diseases [1,4].
1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8–27.
2. Lopez-Castejon G. & Brough D., 2011. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 22(4):189-95.
3. Weber A. et al., 2010. Interleukin-1 (IL-1) pathway. Sci Signal. 3(105):cm1.
4. Dinarello CA., 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720–3732.
THP-1/HEK-Blue™ IL-1β Assay
1. Production of IL-1β by THP-1 cells. Typically, THP-1 cells are pre-treated with phorbol 12-myristate acetate (PMA) to become more susceptible to inflammasome activators, then are primed with lipopolysaccharide (LPS). These treatments induce the production of pro-IL-1β, the immature form of IL-1β. Subsequent stimulation with inflammasome inducers, such as ATP, leads to NRLP3 and caspase-1 activation resulting in IL-1β maturation and secretion.
2. Detection of IL-1β by HEK-Blue™ IL-1β cells. IL-1β-containing THP-1 supernatants are added to HEK-Blue™ IL-1β cells leading to NF-κB activation and the subsequent production of SEAP. The presence of SEAP in HEK-Blue™ IL-1β supernatants is assessed using QUANTI-Blue™ Solution, a SEAP detection medium.
Back to the top